Pharmaceutical Executive

Pharmaceutical Executive Podcast
  • 0.0 (0)
  • CIENCIAS DE LA VIDA
  • DOS VECES A LA SEMANA

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

  1. Pharmaceutical Executive Daily: Mirum Pharmaceuticals Acquires Bluejay Therapeutics

    HACE 1 DÍA

    Pharmaceutical Executive Daily: Mirum Pharmaceuticals Acquires Bluejay Therapeutics

    In todays pharmaceutical executive daily, Mirum Pharmaceuticals strengthens its rare disease portfolio through a $268 million acquisition, industry experts examine why data visualization remains a weak point in biotech decision-making, and pediatricians weigh in on evolving vaccine guidance amid ongoing debate.

    2 min
  2. Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts

    HACE 4 DÍAS

    Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts

    In today’s Pharmaceutical Executive Daily, tariff uncertainty triggers a short-term surge in pharmaceutical manufacturing activity, workforce burnout threatens the stability of the blood supply, and industry leaders assess whether artificial intelligence in pharma is reaching a critical inflection point.

    2 min
  3. Pharmaceutical Executive Daily: United States' Set to Exit WHO

    HACE 5 DÍAS

    Pharmaceutical Executive Daily: United States' Set to Exit WHO

    In today’s Pharmaceutical Executive Daily, the World Health Organization finalizes the United States’ withdrawal from the global health body, Bristol Myers Squibb enters an $850 million collaboration with Janux Therapeutics to advance tumor-activated cancer therapies, and industry leaders examine how real-world data is increasingly shaping patient access decisions.

    2 min
  4. Pharmaceutical Executive Daily: New Study Finds No Evidence Linking Tylenol Use to Autism Risk

    HACE 6 DÍAS

    Pharmaceutical Executive Daily: New Study Finds No Evidence Linking Tylenol Use to Autism Risk

    In today’s Pharmaceutical Executive Daily, a new study reignites debate over a potential link between Tylenol use and autism risk, TopGum signs a $12 million letter of intent to acquire US manufacturing operations, and industry leaders weigh whether to build or buy AI capabilities amid accelerating digital transformation.

    2 min
  5. Pharmaceutical Executive Daily: GSK's $2 Billion Acquisition of RAPT Therapeutics

    HACE 6 DÍAS

    Pharmaceutical Executive Daily: GSK's $2 Billion Acquisition of RAPT Therapeutics

    In today’s Pharmaceutical Executive Daily, GSK moves to strengthen its immunology pipeline with a $2 billion acquisition of RAPT Therapeutics, Atkins launches a new partnership to better understand consumer mindsets around GLP-1 use, and Shionogi agrees to acquire Pfizer’s remaining stake in ViiV Healthcare.

    2 min
  6. Pharmaceutical Executive Daily: Henlius' Exclusive License Agreement with U-Mab Biopharma

    19 ENE

    Pharmaceutical Executive Daily: Henlius' Exclusive License Agreement with U-Mab Biopharma

    In today’s Pharmaceutical Executive Daily, Henlius enters a global exclusive licensing agreement with UMAb Biopharma for a potential best-in-class anti-IL-1RAP antibody, a new report highlights drugmakers raising list prices amid pricing agreements with the Trump administration, and Novartis urges governments to address mounting global trade policy challenges impacting the biopharmaceutical industry.

    2 min
  7. Pharmaceutical Executive Daily: President Trump's Great Healthcare Plan

    16 ENE

    Pharmaceutical Executive Daily: President Trump's Great Healthcare Plan

    In today’s Pharmaceutical Executive Daily, Johnson & Johnson announces plans for a second $2 billion manufacturing facility in North Carolina, President Trump calls on Congress to enact a sweeping healthcare reform package, and new analysis highlights how frontline biopharma sales professionals are rethinking compensation and financial planning strategies.

    2 min
  8. Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference

    15 ENE

    Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference

    In today’s Pharmaceutical Executive Daily we will focus on the 44th Annual J.P. Morgan Healthcare Conference, with Genmab outlining a disciplined strategy focused on sustained growth over the next decade, AbbVie highlighting continued pipeline advancements as it prepares for future revenue transitions, and Novavax detailing its shift toward a partnership-driven operating model.

    2 min
Ver todo (274)

Acerca de

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

Información

  • Creador
    Pharmaceutical Executive Podcast
  • Años de actividad
    2018 - 2026
  • Episodios
    274
  • Clasificación
    Apto
  • Mostrar sitio web
    Pharmaceutical Executive

También te podría interesar